Vulvovaginal Candidiasis caused by non-albicans Candida species: New insights

Current Infectious Disease Reports

Volumn 12, Issue 6, 2010, Pages 465-470

  Kennedy, Melissa A ^a   Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Candida glabrata; Candida parapsilosis; Candida species; Non albicans Candida; Vaginitis; Vulvovaginal candidiasis

Indexed keywords

ANTIFUNGAL AGENT; BORIC ACID; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CLAVISPORA LUSITANIAE; FEMALE; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; VAGINA CANDIDIASIS; VULVOVAGINITIS;

EID: 77958161965     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0137-9     Document Type: Article

References (16)

1. JD Sobel 2007 Vulvovaginal candidosis Lancet 369 1961 71 10.1016/S0140-6736(07)60917-9 17560449 This article provides an extensive review of the epidemiology, diagnosis, and treatment of vaginal Candida infection. (Pubitemid 46874580)
2. JP Vermitsky MJ Self SG Chadwick, et al. 2008 Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection J Clin Microbiol 46 1501 1503 10.1128/JCM.02485-07 18305136 (Pubitemid 351563601)
3. S Mohanty I Xess F Hasan, et al. 2007 Prevalence and susceptibility to fluconazole of Candida species causing vulvovaginitis Indian J Med Res 126 216 219 18037716
4. O Grigoriou S Baka E Makrakis, et al. 2006 Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors Eur J Obstet Gynecol Reprod Biol 126 121 125 10.1016/j.ejogrb.2005.09.015 16256258
5. A Spinillo E Capuzzo R Gulminetti, et al. 1997 Prevalence of and risk factors for fungal vaginitis caused by non-albicans species Am J Obstet Gynecol 176 138 141 1:STN:280:DyaK2s7ns1Gltw%3D%3D 10.1016/S0002-9378(97)80026-9 9024104 (Pubitemid 127780762)
6. SR Fan XP Liu JW Li 2008 Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006 J Obstet Gynaecol Res 34 561 566 10.1111/j.1447-0756.2008.00817.x 18937710
7. N Ahmad AU Khan 2009 Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India Eur J Obstet Gynecol Reprod Biol 144 68 71 10.1016/j.ejogrb.2008.12.020 19261369
8. N Hettiarachchi HR Ashbee JD Wilson 2010 Prevalence and management of non-albicans vaginal candidiasis Sex Trans Infect 86 99 100 10.1136/sti.2009. 040386
9. L Agatensi F Franchi F Mondello, et al. 1991 Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic J Clin Pathol 44 826 830 1:STN:280:DyaK38%2FntFenuw%3D%3D 10.1136/jcp.44.10.826 1960216
10. • Dennerstein GJ, Ellis DE, Reed CS, Bennett CM: The pathogenicity of non-albicans yeasts in the vagina. J Low Genit Tract Dis 2010 (in press). The authors provide convincing evidence that not all NAC infections require therapy.
11. S Singh JD Sobel P Bhargava, et al. 2002 Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy Clin Infect Dis 35 1066 1070 10.1086/343826 12384840 (Pubitemid 35239466)
12. JD Sobel W Chaim V Nagappan D Leaman 2003 Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine Am J Obstet Gynecol 189 1297 1300 1:CAS:528:DC%2BD3sXpt1Squ70%3D 10.1067/S0002-9378(03) 00726-9 14634557 (Pubitemid 37542161)
13. SS Richter RP Galask SA Messer, et al. 2005 Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases J Clin Microbiol 43 2155 2162 1:CAS:528:DC%2BD2MXkvFOqsLw%3D 10.1128/JCM.43.5. 2155-2162.2005 15872235 (Pubitemid 40656220)
14. JD Sobel 2000 Management of infections caused by Candida glabrata Curr Infect Dis Rep 2 424 428 10.1007/s11908-000-0069-x 11095887
15. MA Pfaller DJ Diekema DL Gibbs, et al. 2010 Global Antifungal Surveillance Group: Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program Diagn Microbiol Infect Dis 67 162 171 1:CAS:528:DC%2BC3cXmtFahtb0%3D 10.1016/j.diagmicrobio. 2010.01.002 20338711
16. P Nyirjesy AB Alexander MV Weitz 2005 Vaginal Candida parapsilosis: pathogen or bystander? Infect Dis Obstet Gynecol 13 37 41 16040326